• Report home page • Graphs index • WHO initiatives •
• WHO home page • E-mail comment • Order a copy•
Initiative 14

Providing finance for malarial drugs
WHO's new Medicines for Malaria Venture (MMV) is a joint public-private sector initiative which aims to develop antimalarial drugs and drug combinations for distribution in poor countries. Partners include the World Bank, Global Forum for Health Research, The Rockefeller Foundation and the Wellcome Trust. Industry participants include the International Federation of Pharmaceutical Manufacturers Associations and the Association of British Pharmaceutical Industries.

MMV will help develop new drugs for malaria at a rate of one every five years. MMV will create a fund and operate by financing and resourcing projects in a cost-effective manner. A funding commitment of $15 million a year, rising to $30 million, is being sought. MMV aims to accelerate R&D on new drugs and bring them to the market.

- Medicines for Malaria information can be accessed at www.who.int/ctd

© World Health Organization 1999
About this report